The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
24900776 |
75 |
Discovery of a Novel Class of Imidazo[1,2-a]Pyridines with Potent PDGFR Activity and Oral Bioavailability. |
Array Biopharma |
24900443 |
158 |
Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models. |
TBA |
17210255 |
26 |
Inhibition of FLT3 and PDGFR tyrosine kinase activity by bis(benzo[b]furan-2-yl)methanones. |
University of Regensburg |
16603352 |
89 |
Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases. |
Chiron |
16446087 |
76 |
Design and structure-activity relationship of heterocyclic analogs of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones as inhibitors of receptor tyrosine kinases. |
Chiron |
29152045 |
74 |
Discovery of Indolinone-Based Multikinase Inhibitors as Potential Therapeutics for Idiopathic Pulmonary Fibrosis. |
Shenyang Pharmaceutical University |
10980448 |
3 |
Human liver glycogen phosphorylase inhibitors bind at a new allosteric site. |
Pfizer |
16759861 |
76 |
Structure-activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical development. |
Pfizer |
16913704 |
21 |
Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease. |
National Defense Medical Center |